Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study Using Cisplatin and Gemcitabine (Gemzar) for Advanced Head and Neck Cancer (Squamous Cell Carcinoma)

NCT00003182 is registered in ClinicalTrials.gov with Hope Cancer Institute, Inc. as lead sponsor.

NCT NCT00003182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study Using Cisplatin and Gemcitabine (Gemzar) for Advanced Head and Neck Cancer (Squamous Cell Carcinoma)
Lead sponsor
Hope Cancer Institute, Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 1997
Completion date
Not reported
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer